Cargando…
Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl
BACKGROUND AND OBJECTIVES: The cutaneous fentanyl patch is widely used to treat continuous pain in patients with cancer. Its use is hampered by a high inter- and intrapatient pharmacokinetic variability. Factors that influence this pharmacokinetic variability are largely unclear. The aim of these st...
Autores principales: | Kuip, Evelien J.M., Oldenmenger, Wendy H., Visser-Thijs, Martine F., de Bruijn, Peter, Oomen-de Hoop, Esther, Mathijssen, Ron H.J., Van der Rijt, Carin C.D., Koolen, Stijn W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915071/ https://www.ncbi.nlm.nih.gov/pubmed/29719604 http://dx.doi.org/10.18632/oncotarget.24812 |
Ejemplares similares
-
Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer
por: Kuip, Evelien J. M., et al.
Publicado: (2018) -
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy
por: Kuip, Evelien J. M., et al.
Publicado: (2018) -
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients
por: Oosten, Astrid W., et al.
Publicado: (2016) -
Fungal Endocarditis Secondary to Transdermal Fentanyl Patch
por: Casey, Bradley, et al.
Publicado: (2023) -
Transdermal fentanyl patch in post-operative patients: Is it justified?
por: Nair, Abhijit S
Publicado: (2017)